IL2RA and myeloid sarcoma: Genetic studies have linked MS susceptibility to mutations in human leukocyte antigen (HLA) genes [79], and epigenetic factors—such as methylation of the interleukin-2 receptor alpha gene (IL2RA, SNP rs2104286), which modulates CD8+ T cell function—have also been implicated [80].